Weight management is a personal journey, and medications like semaglutide and tirzepatide may be options for some individuals
Plus, both medications may help with health issues related to being overweight or having obesity, such as joint pain, sleep apnea, and fatigue, says Connor
The STEP trials evaluated semaglutide and showed average weight reductions of around 15% over 68 weeks, while SURMOUNT trialsfocusing on tirzepatide, a dual GIP/GLP-1 receptor agonistdemonstrated even greater reductions, with participants losing up to 21% of their body weight over 72 weeks (Note: GIP = Glucose-dependent insulinotropic polypeptide)
Preservation of Lean Muscle Mass: While promoting fat loss, this stack also helps maintain and even build muscle mass, a critical factor in sustaining weight loss and improving body composition